Eurobio Oncology

How EndoPredict® is Performed

What You Should Know​

  • EndoPredict is performed on tissue that is already collected during your biopsy or surgery.
  • No new sample is needed. No additional appointment is required.
  • The test is carried out in a specialized laboratory and your results are sent to your doctor – usually within a week.

EndoPredict®

Four Steps to Your Result​

1

Talk to your doctor​

Your doctor can help you decide whether EndoPredict is the right test for your situation. It’s used for certain types of breast cancer, especially when treatment decisions are unclear.
The test can be requested from one of the performing pathology labs.
2

Your existing tumor sample is used​

There’s no need for a new procedure. The pathology lab uses a sample of the tumor tissue already taken during your core biopsy or surgery. No additional blood or biopsy samples are required. This means the process is painless for you.
3

The test is performed in a certified lab​

The test is performed in a certified lab to ensure accuracy and reliability. Using advanced gene expression analysis, EndoPredict delivers clear results that combine biological and clinical information to guide treatment decisions.
4

Results in about one week

Within about a week, your doctor receives a clear report with your EndoPredict score. It shows your individual probability of recurrence and helps guide decisions on chemotherapy and other treatments. Your doctor will explain the results and support you in taking the next step with confidence.

Looking Deeper to Give You Clear Answers

Every breast cancer is unique. Your tumor tissue holds valuable biological information that can’t be seen under the microscope.

EndoPredict goes a step further than many other tests: it analyzes both the activity of specific genes in your tumor and key clinical-pathological features such as tumor size and lymph node status. Together, this dual approach provides a more complete picture -helping to answer essential questions for your treatment plan:

  • How likely is it that my cancer will stay in the breast, or show up again elsewhere in the body – either soon or years from now?1
  • Could 5 years of hormone therapy after surgery be enough for me?2
  • Would I benefit from adding chemotherapy to my treatment plan?3

Your Next Appointment - Discussing Your Results and Treatment Options

Once your EndoPredict test results have been sent to your doctor, the next step is to schedule an appointment to review what the results mean for you.

During this appointment, your doctor will:

  • Explain your EndoPredict results: Understanding how likely your cancer is to return helps to personalize your treatment plan.
  • Discuss possible treatment strategies: Based on your EndoPredict results and other important information about you and your cancer, your doctor will discuss the treatment options that are best for you, which may include hormone therapy, chemotherapy, or other approaches.
  • Answer your questions and concerns: This is your opportunity to ask anything about your diagnosis, prognosis, or treatment choices.
  • Plan the next steps together: Your doctor will help you make informed decisions and prepare you for the upcoming phases of your treatment journey.

This appointment marks an important step toward personalized care tailored to your individual situation and needs.

Curious how a Test Result Looks Like?​

Click below to explore how EndoPredict results are presented and what information they include.​

Want to Learn More at Your Own Pace?

  1. Filipits M. et al.: A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors. Clin. Cancer Res. 2011
  2. Filipits M. et al.: Prediction of Distant Recurrence using EndoPredict among Women with ER+, HER2- Node- Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only. Clin Cancer Res. 2019
  3. Sestak I. et al.: Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone. Breast Cancer Res Treat. 2019
en_GB
Scroll to Top